top of page
Dr. Lorenc Featured at ASJ Journal Club
We're proud to share that Dr. Lorenc recently participated in the Aesthetic Surgery Journal Journal Club — a premier forum for expert discussion on the latest in aesthetic surgery research and technique.
A New Chapter in Breast Reconstruction: What Conexeu's B.R.E.A.S.T.™ Could Mean for Patients
Regenerative medicine has long promised more than implants and repair could deliver. Conexeu is working to make that promise real in breast reconstruction, and I am proud to be part of that effort.
Commentary on: Use of LetibotulinumtoxinA for AestheticTreatment of Asians: A Consensus
Aesthetic Surgery Journal, Volume 43, Issue 11, November 2023, Pages NP975–NP976, https://doi.org/10.1093/asj/sjad224 Published: 01...
Galderma unveils final nine-month data showing lasting efficacy with its Injectable Aesthetics portfolio when addressing facial aesthetic changes after medication-driven weight Loss
Galderma unveils final nine-month data showing lasting efficacy and patient satisfaction with its Injectable Aesthetics portfolio when addressing facial aesthetic changes after medication-driven weight loss
The Face of Emotion: Botulinum Toxin, Emotional Anatomy, and Mood Modulation
Robert J. Vanaria1,2 | Aysham Chaudry1 | Angelica C. Marrero-Perez1 | Z. Paul Lorenc3 | Mark S. Nestor1,4,5 ABSTRACT Background: Facial...
Introducing Letybo®: The Newest FDA-Approved Neurotoxin Now Available at Lorenc Aesthetic Plastic Surgery
At Lorenc Aesthetic Plastic Surgery, we are thrilled to announce that we are one of the first practices in the country to offer Letybo®, the
bottom of page